Abstract
Lactobacilli are a part of the human microbiome in healthy humans. Studies of their physiological and genetic characteristics are the basis for their use in probiotic preparations. This report is a brief description of the helveticin gene found in two Lactobacillus crispatus strains, which are a part of the human microbiome. Our analysis showed that the two variants of the gene are not solely characteristic of strains isolated from humans. In the phylogenetic analysis, we found that the studied sequence (this gene) showed a significant difference between the species of the genus Lactobacillus and could be used as a phylogenetic marker.
This is a preview of subscription content, log in via an institution to check access.
References
Bonade A, Murelli F, Vescovo M, Scolari G (2001) Partial characterization of a bacteriocin produced by Lactobacillus helveticus. Lett Appl Microbiol 33:153–158. https://doi.org/10.1046/j.1472-765x.2001.00969.x
Eryilmaz M, Gurpinar SS, Palabiyik IM, Guriz H, Gerceker D (2019) Molecular identification and antimicrobial activity of vaginal Lactobacillus sp. Curr Pharm Biotechnol. https://doi.org/10.2174/1389201020666190110164123
Ghartey JP, Smith BC, Chen Z, Buckley N, Lo Y, Ratner AJ et al (2014) Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PLoS ONE 9(5):e96659. https://doi.org/10.1371/journal.pone.0096659
Green KA, Zarek SM, Catherino WH (2015) Gynecologic health and disease in relation to the microbiome of the female reproductive tract. Fertil Steril 104:1351–1357. https://doi.org/10.1016/j.fertnstert.2015.10.010
Joerger MC, Klaenhammer TR (1990) Cloning, expression, and nucleotide sequence of the Lactobacillus helveticus 481 gene encoding the bacteriocin helveticin J. J Bacteriol 172:6339–6347. https://doi.org/10.1128/jb.172.11.6339-6347.1990
Kovachev SM, Vatcheva-Dobrevska RS (2015) Local probiotic therapy for vaginal Candida albicans infections. Probiotics Antimicrob Proteins 7:38–44. https://doi.org/10.1007/s12602-014-9176-0
Kovachev S (2018) Defence factors of vaginal lactobacilli. Crit Rev Microbiol 44:31–39. https://doi.org/10.1080/1040841X.2017.1306688
Mekadim C, Killer J, Mrázek J, Bunešová V, Pechar R, Hroncová Z, Vlková E (2018) Evaluation of the infB and rpsB gene fragments as genetic markers intended for identification and phylogenetic analysis of particular representatives of the order Lactobacillales. Arch Microbiol 200:1427–1437. https://doi.org/10.1007/s00203-018-1554-7
Ojala T, Kuparinen V, Koskinen JP, Alatalo E, Holm L, Auvinen P et al (2010) Genome sequence of Lactobacillus crispatus ST1. J Bacteriol 192:3547–3548. https://doi.org/10.1128/JB.00399-10
Ojala T, Kankainen M, Castro J, Cerca N, Edelman S, Westerlund-Wikström B et al (2014) Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis. BMC Genom 15(1):1070. https://doi.org/10.1186/1471-2164-15-1070
Petrova MI, Lievens E, Malik S, Imholz N, Lebeer S (2015) Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol 6:81. https://doi.org/10.3389/fphys.2015.00081
Stoyancheva G, Marzotto M, Dellaglio F, Torriani S (2014) Bacteriocin production and gene sequencing analysis from vaginal Lactobacillus strains. Arch Microbiol 196:645–653. https://doi.org/10.1007/s00203-014-1003-1
Sun Z, Wang X, Zhang X, Wu H, Zou Y, Li P et al (2018) Class III bacteriocin Helveticin-M causes sublethal damage on target cells through impairment of cell wall and membrane. J Ind Microbiol Biotechnol 45:213–227. https://doi.org/10.1007/s10295-018-2008-6
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30:2725–2729. https://doi.org/10.1093/molbev/mst197
Terraf MCL, Tomás MSJ, Rault L, Loir LY, Even S, Nader-Macías MEF (2017) In vitro effect of vaginal lactobacilli on the growth and adhesion abilities of uropathogenic Escherichia coli. Arch Microbiol 199:767–774. https://doi.org/10.1007/s00203-016-1336-z
Thompson JK, Collins MA, Mercer WD (1996) Characterization of a proteinaceous antimicrobial produced by Lactobacillus helveticus CNRZ450. J Appl Bacteriol 80:338–348. https://doi.org/10.1111/j.1365-2672.1996.tb03229.x
van Heel AJ, de Jong A, Montalban-Lopez M, Kok J, Kuipers OP (2013) BAGEL3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides. Nucleic Acids Res 41(Web Server issue):W448–W453. https://doi.org/10.1093/nar/gkt391
Vaughan EE, Daly C, Fitzgerald GF (1992) Identification and characterization of helveticin V-1829, a bacteriocin produced by Lactobacillus helveticus 1829. J Appl Bacteriol 73:299–308. https://doi.org/10.1111/j.1365-2672.1992.tb04981.x
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Erko Stackebrandt.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Stoyancheva, G. Study of helveticin gene in Lactobacillus crispatus strains and evaluation of its use as a phylogenetic marker. Arch Microbiol 202, 205–208 (2020). https://doi.org/10.1007/s00203-019-01711-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00203-019-01711-2